Correlation Between Bluejay Diagnostics and OpGen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bluejay Diagnostics and OpGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bluejay Diagnostics and OpGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bluejay Diagnostics and OpGen Inc, you can compare the effects of market volatilities on Bluejay Diagnostics and OpGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bluejay Diagnostics with a short position of OpGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bluejay Diagnostics and OpGen.

Diversification Opportunities for Bluejay Diagnostics and OpGen

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Bluejay and OpGen is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Bluejay Diagnostics and OpGen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OpGen Inc and Bluejay Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bluejay Diagnostics are associated (or correlated) with OpGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OpGen Inc has no effect on the direction of Bluejay Diagnostics i.e., Bluejay Diagnostics and OpGen go up and down completely randomly.

Pair Corralation between Bluejay Diagnostics and OpGen

Given the investment horizon of 90 days Bluejay Diagnostics is expected to under-perform the OpGen. But the stock apears to be less risky and, when comparing its historical volatility, Bluejay Diagnostics is 1.18 times less risky than OpGen. The stock trades about -0.08 of its potential returns per unit of risk. The OpGen Inc is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  3,376  in OpGen Inc on September 23, 2024 and sell it today you would lose (3,186) from holding OpGen Inc or give up 94.37% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy83.3%
ValuesDaily Returns

Bluejay Diagnostics  vs.  OpGen Inc

 Performance 
       Timeline  
Bluejay Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bluejay Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly inconsistent fundamental indicators, Bluejay Diagnostics may actually be approaching a critical reversion point that can send shares even higher in January 2025.
OpGen Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OpGen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, OpGen is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Bluejay Diagnostics and OpGen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bluejay Diagnostics and OpGen

The main advantage of trading using opposite Bluejay Diagnostics and OpGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bluejay Diagnostics position performs unexpectedly, OpGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OpGen will offset losses from the drop in OpGen's long position.
The idea behind Bluejay Diagnostics and OpGen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope